Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners
March 23, 2023 08:46 ET
|
The Insight Partners
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global...
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023 08:00 ET
|
Certara
PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 22, which includes new...
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
February 01, 2023 16:30 ET
|
Certara
PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and...
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
November 07, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and...
Certara to Participate in Upcoming Investor Conferences
November 02, 2022 17:00 ET
|
Certara
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
October 13, 2022 07:45 ET
|
Certara
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Mice Model Market is expected to generate a revenue of USD 2464.65 Million by 2027, Globally, at 7.65% CAGR: Verified Market Research®
September 13, 2022 11:15 ET
|
Verified Market Research
Jersey City, New Jersey, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Mice Model Market” By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice,...
Certara Appoints Eran Broshy as New Independent Board Member
July 13, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
April 20, 2022 08:00 ET
|
Certara
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...
Biopharmaceutical Contract Manufacturing Market to reach US$ 18.7 Billion by 2029 - Comprehensive Research Report by FMI
April 07, 2022 20:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
Top Companies Covered in Biopharmaceutical Contract Manufacturing Market are Catalent Inc., Lonza Group Ag, Patheon N.V. (Thermo Fisher Scientific Inc.), Abzena Plc., Sandoz International GmbH...